Completed
Dasatinib in Imatinib Resistant/Intolerant Chinese CML (Chronic and Advanced Phase) Subjects
NCT00529763
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +2 more
- Locations
-
- Local Institution Beijing, Beijing Municipality, China
- Local Institution - 0004 Fuzhou, Fujian, China
- Local Institution Fuzhou, Fujian, China
- Local Institution Guangzhou, Guangdong, China